Cognex Corporation announced the launch of its In‑Sight 3900 Vision System on May 5 2026. The new platform is a fully integrated, edge‑AI vision system that delivers high‑speed, high‑accuracy inspections without the need for an external PC, allowing manufacturers to maintain line speed while achieving deep inspection coverage.
The In‑Sight 3900 is built on Cognex’s latest embedded AI architecture and is powered by Qualcomm’s Dragonwing™ platforms. The combination of Cognex‑developed edge AI, advanced AI, and rule‑based vision tools enables deterministic, real‑time inspections at full line speed across packaging, automotive, electronics, and consumer goods applications.
By pairing the In‑Sight 3900 with Cognex OneVision™, the company offers a scalable cloud‑to‑edge AI vision ecosystem that lets customers train models centrally while executing inspections locally at production speed. The launch expands Cognex’s product portfolio beyond barcode readers into broader AI‑enabled inspection solutions, positioning the company to capture higher‑value logistics and manufacturing applications.
Matt Moschner, President and CEO of Cognex, said, “The In‑Sight 3900 represents a major leap forward in what embedded AI vision can deliver on the factory floor. Manufacturers no longer have to choose between inspection depth and line speed. We have built a system that delivers both, with the reliability and simplicity Cognex is known for.”
The In‑Sight 3900’s use of Qualcomm’s Dragonwing platform underscores a broader industry trend toward powerful, low‑power processors for edge AI. Competitors such as Keyence, Omron, Basler, and Teledyne Technologies are also investing in AI‑driven vision, but Cognex’s integration of a cloud‑to‑edge ecosystem and its established customer base give it a competitive edge in the market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.